NUVESSA Drug Patent Profile
✉ Email this page to a colleague
When do Nuvessa patents expire, and what generic alternatives are available?
Nuvessa is a drug marketed by Chemo Research Sl and is included in one NDA. There are seven patents protecting this drug and one Paragraph IV challenge.
This drug has sixteen patent family members in nine countries.
The generic ingredient in NUVESSA is metronidazole. There are eighteen drug master file entries for this compound. Sixty-four suppliers are listed for this compound. Additional details are available on the metronidazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nuvessa
A generic version of NUVESSA was approved as metronidazole by TEVA PHARMS USA on November 6th, 1984.
Summary for NUVESSA
International Patents: | 16 |
US Patents: | 7 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 125 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in NUVESSA? | NUVESSA excipients list |
DailyMed Link: | NUVESSA at DailyMed |

Pharmacology for NUVESSA
Drug Class | Nitroimidazole Antimicrobial |
Anatomical Therapeutic Chemical (ATC) Classes for NUVESSA
Paragraph IV (Patent) Challenges for NUVESSA
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
NUVESSA | Vaginal Gel | metronidazole | 1.30% | 205223 | 1 | 2022-03-30 |
US Patents and Regulatory Information for NUVESSA
NUVESSA is protected by seven US patents.
Patents protecting NUVESSA
Aqueous-based metronidazole gel formulations
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Aqueous-based metronidazole gel formulations
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Methods and compositions for increasing solubility of azole drug compounds that are poorly soluble in water
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Methods and compositions for increasing solubility of azole drug compounds that are poorly soluble in water
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF BACTERIAL VAGINOSIS
Compositions for increasing solubility of azole drug compounds that are poorly soluble in water
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
High dosage mucoadhesive metronidazole aqueous-based gel formulations and their use to treat bacterial vaginosis
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF BACTERIAL VAGINOSIS WITH METRONIDAZOLE GEL
Methods of treating bacterial vaginosis with aqueous-based metronidazole gel formulations
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF BACTERIAL VAGINOSIS WITH METRONIDAZOLE GEL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chemo Research Sl | NUVESSA | metronidazole | GEL;VAGINAL | 205223-001 | Mar 24, 2014 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
Chemo Research Sl | NUVESSA | metronidazole | GEL;VAGINAL | 205223-001 | Mar 24, 2014 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
Chemo Research Sl | NUVESSA | metronidazole | GEL;VAGINAL | 205223-001 | Mar 24, 2014 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
Chemo Research Sl | NUVESSA | metronidazole | GEL;VAGINAL | 205223-001 | Mar 24, 2014 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
Chemo Research Sl | NUVESSA | metronidazole | GEL;VAGINAL | 205223-001 | Mar 24, 2014 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for NUVESSA
See the table below for patents covering NUVESSA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Brazil | 112013033759 | formulações de gel de base aquosa de metronidazol mucoadeseivo de alta dosagem e seu uso para tratar vaginose bacteriana | See Plans and Pricing |
China | 103763925 | High dosage mucoadhesive metronidazole aqueous-based gel formulations their use to treat bacterial vaginosis | See Plans and Pricing |
European Patent Office | 2725904 | FORMULATIONS DE GEL À BASE DE MÉTRONIDAZOLE AQUEUX MUCOADHÉSIF À DOSAGE ÉLEVÉ ET LEUR UTILISATION POUR TRAITER UNE VAGINOSE BACTÉRIENNE (HIGH DOSAGE MUCOADHESIVE METRONIDAZOLE AQUEOUS-BASED GEL FORMULATIONS THEIR USE TO TREAT BACTERIAL VAGINOSIS) | See Plans and Pricing |
Japan | 6235087 | See Plans and Pricing | |
Japan | 2017014248 | 高用量粘膜接着性メトロニダゾール水系ゲル製剤および細菌性膣炎を治療するためのそれらの使用 (HIGH-DOSE MUCOADHESIVE METRONIDAZOLE AQUEOUS GEL PREPARATION, AND USE OF THE SAME FOR TREATING BACTERIAL VAGINOSIS) | See Plans and Pricing |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for NUVESSA
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0328535 | 96C0021 | Belgium | See Plans and Pricing | PRODUCT NAME: LANSOPRAZOLE + CLARITHROMYCINE + METRONIDAZOLE; REGISTRATION NO/DATE IN FRANCE: K 27 17033R DU 19960209; REGISTRATION NO/DATE AT EEC: K 27 17033R DU 19960209 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |